Genome-wide association study of conduct disorder symptomatology

D. M. Dick, F. Aliev, R. F. Krueger, A. Edwards, A. Agrawal, M. Lynskey, P. Lin, M. Schuckit, V. Hesselbrock, J. Nurnberger, L. Almasy, B. Porjesz, H. J. Edenberg, K. Bucholz, J. Kramer, S. Kuperman, L. Bierut

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Conduct disorder (CD) is one of the most prevalent childhood psychiatric conditions, and is associated with a number of serious concomitant and future problems. CD symptomatology is known to have a considerable genetic component, with heritability estimates in the range of 50%. Despite this, there is a relative paucity of studies aimed at identifying genes involved in the susceptibility to CD. In this study, we report results from a genome-wide association study of CD symptoms. CD symptoms were retrospectively reported by a psychiatric interview among a sample of cases and controls, in which cases met the criteria for alcohol dependence. Our primary phenotype was the natural log transformation of the number of CD symptoms that were endorsed, with data available for 3963 individuals who were genotyped on the Illumina Human 1M beadchip array. Secondary analyses are presented for case versus control status, in which caseness was established as endorsing three or more CD symptoms (N872 with CD and N3091 without CD). We find four markers that meet the criteria for genome-wide significance (P<5 × 10 -8) with the CD symptom count, two of which are located in the gene C1QTNF7 (C1q and tumor necrosis factor-related protein 7). There were six additional SNPs in the gene that yielded converging evidence of association. These data provide the first evidence of a specific gene that is associated with CD symptomatology. None of the top signals resided in traditional candidate genes, underscoring the importance of a genome-wide approach for identifying novel variants involved in this serious childhood disorder.

Original languageEnglish (US)
Pages (from-to)800-808
Number of pages9
JournalMolecular Psychiatry
Volume16
Issue number8
DOIs
StatePublished - Aug 2011
Externally publishedYes

Fingerprint

Conduct Disorder
Genome-Wide Association Study
Genes
Psychiatry
Genome
Alcoholism
Single Nucleotide Polymorphism
Tumor Necrosis Factor-alpha
Interviews

Keywords

  • association analysis
  • conduct disorder
  • genetics
  • GWAS

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Dick, D. M., Aliev, F., Krueger, R. F., Edwards, A., Agrawal, A., Lynskey, M., ... Bierut, L. (2011). Genome-wide association study of conduct disorder symptomatology. Molecular Psychiatry, 16(8), 800-808. https://doi.org/10.1038/mp.2010.73

Genome-wide association study of conduct disorder symptomatology. / Dick, D. M.; Aliev, F.; Krueger, R. F.; Edwards, A.; Agrawal, A.; Lynskey, M.; Lin, P.; Schuckit, M.; Hesselbrock, V.; Nurnberger, J.; Almasy, L.; Porjesz, B.; Edenberg, H. J.; Bucholz, K.; Kramer, J.; Kuperman, S.; Bierut, L.

In: Molecular Psychiatry, Vol. 16, No. 8, 08.2011, p. 800-808.

Research output: Contribution to journalArticle

Dick, DM, Aliev, F, Krueger, RF, Edwards, A, Agrawal, A, Lynskey, M, Lin, P, Schuckit, M, Hesselbrock, V, Nurnberger, J, Almasy, L, Porjesz, B, Edenberg, HJ, Bucholz, K, Kramer, J, Kuperman, S & Bierut, L 2011, 'Genome-wide association study of conduct disorder symptomatology', Molecular Psychiatry, vol. 16, no. 8, pp. 800-808. https://doi.org/10.1038/mp.2010.73
Dick DM, Aliev F, Krueger RF, Edwards A, Agrawal A, Lynskey M et al. Genome-wide association study of conduct disorder symptomatology. Molecular Psychiatry. 2011 Aug;16(8):800-808. https://doi.org/10.1038/mp.2010.73
Dick, D. M. ; Aliev, F. ; Krueger, R. F. ; Edwards, A. ; Agrawal, A. ; Lynskey, M. ; Lin, P. ; Schuckit, M. ; Hesselbrock, V. ; Nurnberger, J. ; Almasy, L. ; Porjesz, B. ; Edenberg, H. J. ; Bucholz, K. ; Kramer, J. ; Kuperman, S. ; Bierut, L. / Genome-wide association study of conduct disorder symptomatology. In: Molecular Psychiatry. 2011 ; Vol. 16, No. 8. pp. 800-808.
@article{41ca9244075343a8b56b351877dfa7db,
title = "Genome-wide association study of conduct disorder symptomatology",
abstract = "Conduct disorder (CD) is one of the most prevalent childhood psychiatric conditions, and is associated with a number of serious concomitant and future problems. CD symptomatology is known to have a considerable genetic component, with heritability estimates in the range of 50{\%}. Despite this, there is a relative paucity of studies aimed at identifying genes involved in the susceptibility to CD. In this study, we report results from a genome-wide association study of CD symptoms. CD symptoms were retrospectively reported by a psychiatric interview among a sample of cases and controls, in which cases met the criteria for alcohol dependence. Our primary phenotype was the natural log transformation of the number of CD symptoms that were endorsed, with data available for 3963 individuals who were genotyped on the Illumina Human 1M beadchip array. Secondary analyses are presented for case versus control status, in which caseness was established as endorsing three or more CD symptoms (N872 with CD and N3091 without CD). We find four markers that meet the criteria for genome-wide significance (P<5 × 10 -8) with the CD symptom count, two of which are located in the gene C1QTNF7 (C1q and tumor necrosis factor-related protein 7). There were six additional SNPs in the gene that yielded converging evidence of association. These data provide the first evidence of a specific gene that is associated with CD symptomatology. None of the top signals resided in traditional candidate genes, underscoring the importance of a genome-wide approach for identifying novel variants involved in this serious childhood disorder.",
keywords = "association analysis, conduct disorder, genetics, GWAS",
author = "Dick, {D. M.} and F. Aliev and Krueger, {R. F.} and A. Edwards and A. Agrawal and M. Lynskey and P. Lin and M. Schuckit and V. Hesselbrock and J. Nurnberger and L. Almasy and B. Porjesz and Edenberg, {H. J.} and K. Bucholz and J. Kramer and S. Kuperman and L. Bierut",
year = "2011",
month = "8",
doi = "10.1038/mp.2010.73",
language = "English (US)",
volume = "16",
pages = "800--808",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Genome-wide association study of conduct disorder symptomatology

AU - Dick, D. M.

AU - Aliev, F.

AU - Krueger, R. F.

AU - Edwards, A.

AU - Agrawal, A.

AU - Lynskey, M.

AU - Lin, P.

AU - Schuckit, M.

AU - Hesselbrock, V.

AU - Nurnberger, J.

AU - Almasy, L.

AU - Porjesz, B.

AU - Edenberg, H. J.

AU - Bucholz, K.

AU - Kramer, J.

AU - Kuperman, S.

AU - Bierut, L.

PY - 2011/8

Y1 - 2011/8

N2 - Conduct disorder (CD) is one of the most prevalent childhood psychiatric conditions, and is associated with a number of serious concomitant and future problems. CD symptomatology is known to have a considerable genetic component, with heritability estimates in the range of 50%. Despite this, there is a relative paucity of studies aimed at identifying genes involved in the susceptibility to CD. In this study, we report results from a genome-wide association study of CD symptoms. CD symptoms were retrospectively reported by a psychiatric interview among a sample of cases and controls, in which cases met the criteria for alcohol dependence. Our primary phenotype was the natural log transformation of the number of CD symptoms that were endorsed, with data available for 3963 individuals who were genotyped on the Illumina Human 1M beadchip array. Secondary analyses are presented for case versus control status, in which caseness was established as endorsing three or more CD symptoms (N872 with CD and N3091 without CD). We find four markers that meet the criteria for genome-wide significance (P<5 × 10 -8) with the CD symptom count, two of which are located in the gene C1QTNF7 (C1q and tumor necrosis factor-related protein 7). There were six additional SNPs in the gene that yielded converging evidence of association. These data provide the first evidence of a specific gene that is associated with CD symptomatology. None of the top signals resided in traditional candidate genes, underscoring the importance of a genome-wide approach for identifying novel variants involved in this serious childhood disorder.

AB - Conduct disorder (CD) is one of the most prevalent childhood psychiatric conditions, and is associated with a number of serious concomitant and future problems. CD symptomatology is known to have a considerable genetic component, with heritability estimates in the range of 50%. Despite this, there is a relative paucity of studies aimed at identifying genes involved in the susceptibility to CD. In this study, we report results from a genome-wide association study of CD symptoms. CD symptoms were retrospectively reported by a psychiatric interview among a sample of cases and controls, in which cases met the criteria for alcohol dependence. Our primary phenotype was the natural log transformation of the number of CD symptoms that were endorsed, with data available for 3963 individuals who were genotyped on the Illumina Human 1M beadchip array. Secondary analyses are presented for case versus control status, in which caseness was established as endorsing three or more CD symptoms (N872 with CD and N3091 without CD). We find four markers that meet the criteria for genome-wide significance (P<5 × 10 -8) with the CD symptom count, two of which are located in the gene C1QTNF7 (C1q and tumor necrosis factor-related protein 7). There were six additional SNPs in the gene that yielded converging evidence of association. These data provide the first evidence of a specific gene that is associated with CD symptomatology. None of the top signals resided in traditional candidate genes, underscoring the importance of a genome-wide approach for identifying novel variants involved in this serious childhood disorder.

KW - association analysis

KW - conduct disorder

KW - genetics

KW - GWAS

UR - http://www.scopus.com/inward/record.url?scp=79960835594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960835594&partnerID=8YFLogxK

U2 - 10.1038/mp.2010.73

DO - 10.1038/mp.2010.73

M3 - Article

C2 - 20585324

AN - SCOPUS:79960835594

VL - 16

SP - 800

EP - 808

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 8

ER -